Regenerx Biopharm In Probability of Future OTC Stock Price Finishing Under 0.04
| RGRXDelisted Stock | USD 0.03 0.01 25.00% |
Regenerx |
Regenerx Biopharm Target Price Odds to finish below 0.04
The tendency of Regenerx OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 0.04 after 90 days |
| 0.03 | 90 days | 0.04 | about 46.95 |
Based on a normal probability distribution, the odds of Regenerx Biopharm to stay under $ 0.04 after 90 days from now is about 46.95 (This Regenerx Biopharm In probability density function shows the probability of Regenerx OTC Stock to fall within a particular range of prices over 90 days) . Probability of Regenerx Biopharm price to stay between its current price of $ 0.03 and $ 0.04 at the end of the 90-day period is about 19.5 .
Given the investment horizon of 90 days Regenerx Biopharm In has a beta of -7.65 indicating as returns on its benchmark rise, returns on holding Regenerx Biopharm In are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Regenerx Biopharm is expected to outperform its benchmark. In addition to that Regenerx Biopharm In has an alpha of 2.8588, implying that it can generate a 2.86 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Regenerx Biopharm Price Density |
| Price |
Predictive Modules for Regenerx Biopharm
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Regenerx Biopharm. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Regenerx Biopharm Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Regenerx Biopharm is not an exception. The market had few large corrections towards the Regenerx Biopharm's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Regenerx Biopharm In, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Regenerx Biopharm within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 2.86 | |
β | Beta against Dow Jones | -7.65 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.09 |
Regenerx Biopharm Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Regenerx Biopharm for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Regenerx Biopharm can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Regenerx Biopharm is not yet fully synchronised with the market data | |
| Regenerx Biopharm has some characteristics of a very speculative penny stock | |
| Regenerx Biopharm has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 76.76 K. Net Loss for the year was (1.6 M) with profit before overhead, payroll, taxes, and interest of 70.12 K. | |
| Regenerx Biopharm In currently holds about 478.41 K in cash with (990.3 K) of positive cash flow from operations. | |
| Roughly 46.0% of the company outstanding shares are owned by corporate insiders |
Regenerx Biopharm Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Regenerx OTC Stock often depends not only on the future outlook of the current and potential Regenerx Biopharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regenerx Biopharm's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 143.5 M |
Regenerx Biopharm Technical Analysis
Regenerx Biopharm's future price can be derived by breaking down and analyzing its technical indicators over time. Regenerx OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regenerx Biopharm In. In general, you should focus on analyzing Regenerx OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Regenerx Biopharm Predictive Forecast Models
Regenerx Biopharm's time-series forecasting models is one of many Regenerx Biopharm's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Regenerx Biopharm's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Regenerx Biopharm
Checking the ongoing alerts about Regenerx Biopharm for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Regenerx Biopharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Regenerx Biopharm is not yet fully synchronised with the market data | |
| Regenerx Biopharm has some characteristics of a very speculative penny stock | |
| Regenerx Biopharm has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 76.76 K. Net Loss for the year was (1.6 M) with profit before overhead, payroll, taxes, and interest of 70.12 K. | |
| Regenerx Biopharm In currently holds about 478.41 K in cash with (990.3 K) of positive cash flow from operations. | |
| Roughly 46.0% of the company outstanding shares are owned by corporate insiders |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Regenerx OTC Stock
If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |